Global Chronic Disease Management Market Size, Share, and Growth & Trends Analysis By Disease Type (Cardiovascular diseases, Diabetes, Cancer, Asthma, Chronic obstructive pulmonary disorders, Others) By Type (Solutions, Services) By End User (Healthcare Providers, Healthcare Payers, Others) By Region (North America, Asia Pacific, Europe, Middle East & Africa, South America): Regional Outlook, Growth Potential and Segments Forecast 2024-2031

Loading...

Budget constraints? Get in touch with us for special pricing

Buying Options

Original price was: $6,000.00.Current price is: $5,100.00.
Original price was: $5,000.00.Current price is: $4,500.00.
Original price was: $4,000.00.Current price is: $3,800.00.
Loading...

Description

The Global Chronic Disease Management Market size was USD $ 4.90 billion in 2023 and is projected to reach USD 7.4 billion by 2031, with a CAGR of 12 % during the forecast period. 

Global Chronic Disease Management Market: Overview

The chronic disease management market continues to grow as chronic disorders become more common and patients expect improved results. The incorporation of Electronic Health Records (EHR) is a key development shaping this industry because it centralises patient knowledge and allows for data-driven choices across healthcare teams. For instance, the United States Department of Health and Human Services has made major investments in the setup of EHR systems to better chronic disease management. Precision medicine and genetic therapy provide personalised treatments based on genetic profiles, which improves treatment efficacy. Recently, the FDA authorised numerous gene treatments, like Zolgensma for spinal muscular atrophy and Luxturna for inherited retinal illnesses. Clinical Decision Support Systems (CDSS) give recommendations based on evidence for optimising patient care decisions, with businesses like Epic and Cerner developing advanced CDSS solutions.

Digital therapeutics, powered by software, provide evidence-based interventions to control or treat medical diseases, frequently supplementing traditional treatments. Notable examples are Pear Therapeutics’ reSET-O for opioid use disorder and Voluntis’ Insulia for diabetic treatment. At-home care technologies, such as remote monitoring devices and telehealth platforms, allow for simple patient management at home, lowering hospital visits and expenses while increasing patient comfort. For example, during the COVID-19 epidemic, Philips’ remote patient monitoring technology and Teladoc’s virtual care services saw increasing popularity. These advancements underscore a shift towards personalized, data-driven, and accessible chronic disease management strategies aimed at enhancing patient outcomes and healthcare efficiency.

Global Chronic Disease Management Market: Covid-19 Impact

The COVID-19 pandemic has significantly impacted the chronic disease management market, accelerating trends towards telemedicine and remote monitoring technologies. Healthcare providers increasingly adopt digital solutions to manage chronic conditions remotely, ensuring continuity of care while minimizing patient exposure. Pharmaceutical companies focus on developing treatments addressing both COVID-19 complications and chronic diseases. This dual approach reshapes the market landscape, emphasizing innovation in virtual care and integrated health management solutions.

Global Chronic Disease Management Market: Growth Drivers

  • Increasing Prevalence of Chronic Diseases:

The rising incidence of chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders is a significant driver. Factors contributing to this include aging populations, sedentary lifestyles, and changing dietary habits.

  • Technological Advancements in Healthcare:

Innovations in medical technology, including telemedicine, wearable devices, and digital health platforms, have revolutionized chronic disease management. These technologies enhance monitoring, improve treatment adherence, and enable remote patient management.

  • Government Initiatives and Healthcare Reforms:

Supportive healthcare policies, funding for chronic disease management programs, and initiatives aimed at preventive care contribute to market growth. These efforts focus on reducing healthcare costs associated with chronic diseases through early intervention and better disease management strategies.

Global Chronic Disease Management Market: Restraining Factors

  • High Cost of Treatment and Care:

Chronic disease management often involves expensive medications, regular consultations, and monitoring equipment, posing financial challenges for patients and healthcare systems alike. Cost barriers can limit access to advanced treatments and technologies, especially in low-income regions.

  • Data Privacy and Security Concerns:

With the adoption of digital health solutions, there are growing concerns about the privacy and security of patient data. Issues such as data breaches, unauthorized access, and compliance with stringent regulations (e.g., GDPR, HIPAA) pose significant challenges to the widespread adoption of digital health technologies.

Global Chronic Disease Management Market:  Opportunity Factors

  • Expansion of Telehealth Services:

The rapid expansion of telehealth services presents opportunities for enhancing chronic disease management. Telemedicine facilitates remote consultations, real-time monitoring of patient health metrics, and access to healthcare professionals, particularly in underserved rural areas.

  • Personalized Medicine and Precision Healthcare:

Advances in genomics, biomarker research, and AI-driven analytics are paving the way for personalized approaches to chronic disease management. Tailored treatments based on genetic profiles and predictive analytics promise more effective outcomes and improved patient compliance. 

Global Chronic Disease Management Market: Challenges

  • Integration of Healthcare Systems:

Effective chronic disease management often requires seamless integration of various healthcare systems, including electronic health records (EHRs), patient portals, and diagnostic tools. Achieving interoperability among different platforms and data sources remains a complex challenge.

  • Patient Engagement and Adherence:

Ensuring patient engagement and adherence to treatment plans over the long term poses a significant challenge. Factors such as patient education, socio-economic disparities, cultural beliefs, and behavioural factors influence patient participation in disease management programs.

Global Chronic Disease Management Market: Segmentation

Based on Disease Type: The market is segmented into Cardiovascular diseases, Diabetes, Cancer, Asthma, Chronic obstructive pulmonary disorders, Others.

Based on Application: The market is segmented into Solutions, Services.

Based on End User: The market is segmented into Healthcare Providers, Healthcare Payers, Others.

Global Chronic Disease Management Market: Regional Insights

  • North America:

The chronic illness management market in North America is seeing rapid expansion due to the rising prevalence of chronic diseases such as diabetes, cardiovascular disease, and respiratory disorders. For example, the American Diabetes Association estimated that more than 37 million Americans would have diabetes in 2021, emphasising the importance of comprehensive chronic illness management options.

Rising healthcare costs, technological improvements such as telemedicine, and positive government initiatives to assist chronic disease management programmes all contribute to market growth. The United States Centres for Medicare and Medicaid Services have introduced value-based care models that encourage healthcare providers to prioritise chronic illness treatment and patient outcomes. Furthermore, firms such as Philips and Teladoc have introduced remote patient monitoring equipment and virtual care services to allow for easy at-home management of chronic illnesses.

Key players in the region focus on developing innovative solutions including remote patient monitoring systems, digital health platforms, and personalized medicine approaches to improve patient outcomes and reduce healthcare costs. For example, Medtronic’s Diabetes Management Platform integrates continuous glucose monitoring, insulin delivery, and mobile apps to provide personalized diabetes care. Integration of artificial intelligence and data analytics into healthcare systems, as seen with Epic’s Clinical Decision Support System, enhances treatment efficacy and patient engagement.

  • Asia Pacific:

The Asia Pacific chronic disease management market is witnessing significant growth driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer. For instance, the International Diabetes Federation reported that the number of adults with diabetes in the Western Pacific region, which includes countries like China and Japan, reached 206 million in 2021.

Factors contributing to this growth include increasing geriatric population, changing lifestyles, and improvements in healthcare infrastructure. The United Nations Population Division estimates that the number of people aged 65 and above in Asia is projected to increase from 395 million in 2022 to 536 million by 2030. Governments and healthcare providers are focusing on promoting early diagnosis and effective management of chronic conditions through advanced technologies and patient-centric approaches. For example, the Australian government launched the National Strategic Framework for Chronic Conditions in 2017 to guide the development of policies and programs for chronic disease prevention and management. Telemedicine and digital health solutions are gaining traction, enhancing access to care in remote areas. Companies like Philips and Medtronic have launched remote patient monitoring devices and telehealth platforms tailored to the Asia Pacific market. Moreover, pharmaceutical companies are investing in research and development of innovative therapies tailored to regional healthcare needs. AstraZeneca recently announced the launch of its Farxiga (dapagliflozin) drug for the treatment of heart failure in Japan.

Global Chronic Disease Management Market: Competitive Landscape

Cedar Gate Technologies, Cognizant TriZetto Software Group Inc, Hinduja Global Solutions Ltd, Altruista Health, Koninklijke Philips N.V, Health Catalyst, ExlServings Holdings, Inc, Vivify Health, Inc, Pegasystems Inc, Epic Systems Corporation, Medecision, Casenet, LLC, cliexa, Inc, ZeOmega, NXGN Management, LLC, Infosys Ltd, Allscripts Healthcare, LLC

Global Chronic Disease Management Market: Recent Developments

  • APRIL 2024, Cedar Gate Technologies (Cedar Gate) announced that an analysis of their national Healthcare Benchmark Database, encompassing nearly 13 million member lives, revealed a potential savings opportunity of approximately $1.4 billion. Machine learning models within Cedar Gate’s platform can identify, with a high level of accuracy, patients who are at risk of coronary artery disease (CAD) and congestive heart failure (CHF), allowing for early intervention and, as a result, the potential to reduce acute events.
  • June 2024, As part of an expanded partnership announced last August, Cognizant has launched the first set of healthcare large language model (LLM) solutions on Google Cloud’s generative AI (genAI) technology, including the company’s Vertex AI platform and Gemini models, aimed at redesigning healthcare administrative processes and improving experiences.

Table of Content

CHAPTER 1: EXECUTIVE SUMMARY
1.1. Summary
CHAPTER 2: RESEARCH METHODOLOGY
2.1. Research Process
2.2. Primary Research
2.3. Secondary Research
2.4. Market Size Estimation
2.5. Research Methodology
2.6. Analyst Tools/Models/Techniques
2.6.1. Notations
2.7. Market Scope & Segmentation
2.8. Currency & Pricing Considered
CHAPTER 3: MARKET TRENDS
3.1. Introduction
3.2. Drivers
3.2.1. Increasing Prevalence of Chronic Diseases
3.3. Restraints
3.3.1. High Cost of Treatment and Care
3.4. Opportunities
3.4.1. Expansion of Telehealth Services
3.5. Challenges
3.5.1. Integration of Healthcare Systems
3.6. Investment Feasibility Analysis
3.7. Latest Trends
CHAPTER 4: MARKET ASSESSMENT
4.1. Porters Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitute
4.1.5. Intensity of Competitive Rivalry
4.2. Value Chain Analysis
4.3. Market Share Analysis
4.4. Impact of Key Regulations on the Market
4.5. SWOT Analysis
4.6. PESTEL Analysis
4.7. Patent Analysis
4.7.1. BY DISEASE TYPE
4.7.2. BY APPLICATION
4.7.3. BY END USER
4.8. Roadmap Development
4.9. Market Lineage Outlook
4.9.1. Parent Market Outlook
4.9.2. Ancillary Market Outlook
CHAPTER 5: IMPACT OF RECESSION ON THE MARKET
5.1. Introduction
5.1.1. Short Term Impact
5.1.2. Long Term Impact
CHAPTER 6: GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE
6.1. Introduction
6.1.1. Market Size & Forecast
6.1.2. Global Chronic Disease Management MarketShare, BY Disease Type -2023 and 2031 (%)
6.2. CARDIOVASCULAR DISEASES
6.2.1. Key market Trends, Growth Factors, and Opportunities
6.2.2. Market Size and Forecast, by Regions
6.3. DIABETES
6.3.1. Key market Trends, Growth Factors, and Opportunities
6.3.2. Market Size and Forecast, by Regions
6.4. CANCER
6.4.1. Key market Trends, Growth Factors, and Opportunities
6.4.2. Market Size and Forecast, by Regions
6.5. ASTHMA
6.5.1. Key market Trends, Growth Factors, and Opportunities
6.5.2. Market Size and Forecast, by Regions
6.6. CHRONIC OBSTRUCTIVE PULMONARY DISORDERS
6.6.1. Key market Trends, Growth Factors, and Opportunities
6.6.2. Market Size and Forecast, by Regions
6.7. OTHERS
6.7.1. Key market Trends, Growth Factors, and Opportunities
6.7.2. Market Size and Forecast, by Regions
CHAPTER 7: GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size & Forecast
7.1.2. Global Chronic Disease Management MarketShare, By End User -2023 and 2031 (%)
7.2. SOLUTIONS
7.2.1. Key market Trends, Growth Factors, and Opportunities
7.2.2. Market Size and Forecast, by Regions
7.3. SERVICES
7.3.1. Key market Trends, Growth Factors, and Opportunities
7.3.2. Market Size and Forecast, by Regions
CHAPTER 8: GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY END USER
8.1. Introduction
8.1.1. Market Size & Forecast
8.1.2. Chronic Disease Management MarketShare, By End User -2023 and 2031 (%)
8.2. HEALTHCARE PROVIDERS
8.2.1. Key market Trends, Growth Factors, and Opportunities
8.2.2. Market Size and Forecast, by Regions
8.3. HEALTHCARE PAYERS
8.3.1. Key market Trends, Growth Factors, and Opportunities
8.3.2. Market Size and Forecast, by Regions
8.4. OTHERS
8.4.1. Key market Trends, Growth Factors, and Opportunities
8.4.2. Market Size and Forecast, by Regions
CHAPTER 9: NORTH AMERICA MARKET ANALYSIS
9.1. Introduction
9.2. Chronic Disease Management MarketBy Country
9.3. North America Chronic Disease Management Marketby Country, USD Million 2019-2031
9.3.1. Market Size & Forecast, BY Disease Type
9.3.2. Market Size & Forecast, By Application
9.3.3. Market Size & Forecast, By End User
9.4. U.S.
9.4.1. Market Size & Forecast, BY Disease Type
9.4.2. Market Size & Forecast, By Application
9.4.3. Market Size & Forecast, By End User
9.5. Canada
9.5.1. Market Size & Forecast, BY Disease Type
9.5.2. Market Size & Forecast, By Application
9.5.3. Market Size & Forecast, By End User
CHAPTER 10: EUROPE MARKET ANALYSIS
10.1. Introduction
10.2. Chronic Disease Management Marketby Country
10.3. Europe Chronic Disease Management Marketby Country, USD Million 2019-2031
10.3.1. Market Size & Forecast, BY Disease Type
10.3.2. Market Size & Forecast, By Application
10.3.3. Market Size & Forecast, By End User
10.4. Germany
10.4.1. Market Size & Forecast, BY Disease Type
10.4.2. Market Size & Forecast, By Application
10.4.3. Market Size & Forecast, By End User
10.5. France
10.5.1. Market Size & Forecast, BY Disease Type
10.5.2. Market Size & Forecast, By Application
10.5.3. Market Size & Forecast, By End User
10.6. U.K.
10.6.1. Market Size & Forecast, BY Disease Type
10.6.2. Market Size & Forecast, By Application
10.6.3. Market Size & Forecast, By End User
10.7. Italy
10.7.1. Market Size & Forecast, BY Disease Type
10.7.2. Market Size & Forecast, By Application
10.7.3. Market Size & Forecast, By End User
10.8. Spain
10.8.1. Market Size & Forecast, BY Disease Type
10.8.2. Market Size & Forecast, By Application
10.8.3. Market Size & Forecast, By End User
10.9. Benelux
10.9.1. Market Size & Forecast, BY Disease Type
10.9.2. Market Size & Forecast, By Application
10.9.3. Market Size & Forecast, By End User
10.10. Rest of Europe
10.10.1. Market Size & Forecast, BY Disease Type
10.10.2. Market Size & Forecast, By Application
10.10.3. Market Size & Forecast, By End User
CHAPTER 11: ASIA-PACIFIC MARKET ANALYSIS
11.1. Introduction
11.2. Chronic Disease Management Marketby Country
11.3. Asia Pacific Chronic Disease Management Marketby Country, USD Million 2019-2031
11.3.1. Market Size & Forecast, BY Disease Type
11.3.2. Market Size & Forecast, By Application
11.3.3. Market Size & Forecast, By End User
11.4. China
11.4.1. Market Size & Forecast, BY Disease Type
11.4.2. Market Size & Forecast, By Application
11.4.3. Market Size & Forecast, By End User
11.5. India
11.5.1. Market Size & Forecast, BY Disease Type
11.5.2. Market Size & Forecast, By Application
11.5.3. Market Size & Forecast, By End User
11.6. Japan
11.6.1. Market Size & Forecast, BY Disease Type
11.6.2. Market Size & Forecast, By Application
11.6.3. Market Size & Forecast, By End User
11.7. Australia
11.7.1. Market Size & Forecast, BY Disease Type
11.7.2. Market Size & Forecast, By Application
11.7.3. Market Size & Forecast, By End User
11.8. South Korea
11.8.1. Market Size & Forecast, BY Disease Type
11.8.2. Market Size & Forecast, By Application
11.8.3. Market Size & Forecast, By End User
11.9. Souethest Asia
11.9.1. Market Size & Forecast, BY Disease Type
11.9.2. Market Size & Forecast, By Application
11.9.3. Market Size & Forecast, By End User
11.10. Rest of Asia Pacific
11.10.1. Market Size & Forecast, BY Disease Type
11.10.2. Market Size & Forecast, By Application
11.10.3. Market Size & Forecast, By End User
CHAPTER 12: LATIN AMERICA AND THE CARIBBEAN MARKET ANALYSIS
12.1. Introduction
12.2. Chronic Disease Management Marketby Country
12.3. Latin America Chronic Disease Management Marketby Country, USD Million 2019-2031
12.3.1. Market Size & Forecast, BY Disease Type
12.3.2. Market Size & Forecast, By Application
12.3.3. Market Size & Forecast, By End User
12.4. Brazil
12.4.1. Market Size & Forecast, BY Disease Type
12.4.2. Market Size & Forecast, By Application
12.4.3. Market Size & Forecast, By End User
12.5. Mexico
12.5.1. Market Size & Forecast, BY Disease Type
12.5.2. Market Size & Forecast, By Application
12.5.3. Market Size & Forecast, By End User
12.6. Rest of Latin America
12.6.1. Market Size & Forecast, BY Disease Type
12.6.2. Market Size & Forecast, By Application
12.6.3. Market Size & Forecast, By End User
CHAPTER 13: THE MIDDLE EAST AND AFRICA MARKET ANALYSIS
13.1. Introduction
13.2. Chronic Disease Management Marketby Country
13.3. MEA Chronic Disease Management Marketby Country, USD Million 2019-2031
13.3.1. Market Size & Forecast, BY Disease Type
13.3.2. Market Size & Forecast, By Application
13.3.3. Market Size & Forecast, By End User
13.4. South Africa
13.4.1. Market Size & Forecast, BY Disease Type
13.4.2. Market Size & Forecast, By Application
13.4.3. Market Size & Forecast, By End User
13.5. Saudi Arabia
13.5.1. Market Size & Forecast, BY Disease Type
13.5.2. Market Size & Forecast, By Application
13.5.3. Market Size & Forecast, By End User
13.6. UAE
13.6.1. Market Size & Forecast, BY Disease Type
13.6.2. Market Size & Forecast, By Application
13.6.3. Market Size & Forecast, By End User
13.7. Rest of MEA
13.7.1. Market Size & Forecast, BY Disease Type
13.7.2. Market Size & Forecast, By Application
13.7.3. Market Size & Forecast, By End User
CHAPTER 14: COMPETITIVE LANDSCAPE
14.1. Introduction
14.2. Market Player Positioning, 2022
14.3. Company Evaluation Matrix
14.4. Product Mapping of Top 10 Player
14.5. Market Opportunities and Future Trends
14.6. Competitive Heatmap
14.7. Top Winning Growth Strategies
14.7.1. Major Growth Strategies
14.7.2. Expansion
14.7.3. Merger and Acquisition
14.7.4. Other Developments
CHAPTER 15: COMPANY PROFILES
15.1. CEDAR GATE TECHNOLOGIES
15.1.1. Company Overview
15.1.2. Key Executives
15.1.3. Financial Overview
15.1.4. Business Applicationnalysis
15.1.5. Product Portfolio
15.1.6. Key Strategic Developments
15.2. COGNIZANT TRIZETTO SOFTWARE GROUP INC
15.3. HINDUJA GLOBAL SOLUTIONS LTD
15.4. ALTRUISTA HEALTH
15.5. KONINKLIJKE PHILIPS N.V
15.6. HEALTH CATALYST
15.7. EXLSERVINGS HOLDINGS, INC
15.8. VIVIFY HEALTH, INC
15.9. PEGASYSTEMS INC
15.10. EPIC SYSTEMS CORPORATION
15.11. MEDECISION
15.12. CASENET, LLC
15.13. CLIEXA, INC
15.14. ZEOMEGA
15.15. NXGN MANAGEMENT, LLC
15.16. INFOSYS LTD
15.17. ALLSCRIPTS HEALTHCARE, LLC

Tables & Figures

LIST OF TABLES
Table 1. Global Chronic Disease Management Market INDUSTRY SNAPSHOT, 2022-2031
Table 2. Global Chronic Disease Management Market SHARE, By Disease Type -2019-2031 (USD MILLION)
Table 3. Global Chronic Disease Management Market CARDIOVASCULAR DISEASES, BY REGION-2019-2031 (USD MILLION)
Table 4. Global Chronic Disease Management Market DIABETES, BY REGION-2019-2031 (USD MILLION)
Table 5. Global Chronic Disease Management Market ASTHMA, BY REGION-2019-2031 (USD MILLION)
Table 6. Global Chronic Disease Management Market CHRONIC OBSTRUCTIVE PULMONARY DISORDERS, BY REGION-2019-2031 (USD MILLION)
Table 7. Global Chronic Disease Management Market OTHERS, BY REGION-2019-2031 (USD MILLION)
Table 8. Global Chronic Disease Management Market SHARE, By Application SIZE-2019-2031 (USD MILLION)
Table 9. Global Chronic Disease Management Market SOLUTIONS, BY REGION-2019-2031 (USD MILLION)
Table 10. Global Chronic Disease Management Market SERVICES, BY REGION-2019-2031 (USD MILLION)
Table 11. Global Chronic Disease Management Market SHARE, By End User -2019-2031 (USD MILLION)
Table 12. Global Chronic Disease Management Market HEALTHCARE PROVIDERS, BY REGION-2019-2031 (USD MILLION)
Table 13. Global Chronic Disease Management Market HEALTHCARE PAYERS, BY REGION-2019-2031 (USD MILLION)
Table 14. NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET BY COUNTRY, USD MILLION 2019-2031
Table 15. NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 16. NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 17. NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 18. U.S. CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 19. U.S. CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 20. U.S. CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 21. CANADA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 22. CANADA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 23. CANADA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 24. EUROPE CHRONIC DISEASE MANAGEMENT MARKET BY COUNTRY, USD MILLION 2019-2031
Table 25. EUROPE CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 26. EUROPE CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 27. EUROPE CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 28. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 29. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 30. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 31. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 32. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 33. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 34. UK CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 35. UK CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 36. UK CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 37. ITALY CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 38. ITALY CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 39. ITALY CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 40. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 41. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 42. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 43. BENELUX CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 44. BENELUX CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 45. BENELUX CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 46. REST OF EUROPE CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 47. REST OF EUROPE CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 48. REST OF EUROPE CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 49. ASIA PACIFIC CHRONIC DISEASE MANAGEMENT MARKET BY COUNTRY, USD MILLION 2019-2031
Table 50. ASIA PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 51. ASIA PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 52. ASIA PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 53. CHINA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 54. CHINA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 55. CHINA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 56. INDIA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 57. INDIA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 58. INDIA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 59. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 60. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 61. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 62. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 63. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 64. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 65. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 66. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 67. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 68. SOUETHEST ASIA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 69. SOUETHEST ASIA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 70. SOUETHEST ASIA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 71. REST OF ASIA PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 72. REST OF ASIA PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 73. REST OF ASIA PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 74. LATIN AMERICA CHRONIC DISEASE MANAGEMENT MARKET BY COUNTRY, USD MILLION 2019-2031
Table 75. LATIN AMERICA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 76. LATIN AMERICA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 77. LATIN AMERICA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 78. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 79. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 80. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 81. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 82. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 83. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 84. REST OF LATIN AMERICA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 85. REST OF LATIN AMERICA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 86. REST OF LATIN AMERICA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 87. MEA CHRONIC DISEASE MANAGEMENT MARKET BY COUNTRY, USD MILLION 2019-2031
Table 88. MEA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 89. MEA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 90. MEA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 91. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 92. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 93. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 94. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 95. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 96. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 97. UAE CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 98. UAE CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 99. UAE CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 100. REST OF MEA CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY Disease Type -2019-2031 (USD MILLION)
Table 101. REST OF MEA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By Application -2019-2031 (USD MILLION)
Table 102. REST OF MEA CHRONIC DISEASE MANAGEMENT MARKET SHARE, By End User – 2019-2031 (USD MILLION)
Table 103. KEY EXPANSIONS (2019-2022)
Table 104. KEY MERGERS AND ACQUISITION (2019-2022)
Table 105. OTHER KEY DEVELOPMENTS (2019-2022)

LIST OF FIGURES
Figure 1. REGIONAL ANALYSIS (2022 & 2031)
Figure 2. RESEARCH PROCESS
Figure 3. ANALYSIS FRAMEWORK
Figure 4. IMPACT OF KEY REGULATION ON THE MARKET
Figure 5. SWOT ANALYSIS
Figure 6. Global Chronic Disease Management Market SHARE, BY Disease Type -2023 & 2031 (USD MILLION)
Figure 7. Global Chronic Disease Management Market, CARDIOVASCULAR DISEASES -2019-2031 (USD MILLION)
Figure 8. Global Chronic Disease Management Market, DIABETES -2019-2031 (USD MILLION)
Figure 9. Global Chronic Disease Management Market, CANCER -2019-2031 (USD MILLION)
Figure 10. Global Chronic Disease Management Market, ASTHMA -2019-2031 (USD MILLION)
Figure 11. Global Chronic Disease Management Market, CHRONIC OBSTRUCTIVE PULMONARY DISORDERS -2019-2031 (USD MILLION)
Figure 12. Global Chronic Disease Management Market, OTHERS -2019-2031 (USD MILLION)
Figure 13. Global Chronic Disease Management Market SHARE, By Application -2023 & 2031 (USD MILLION)
Figure 14. Global Chronic Disease Management Market, SOLUTIONS -2019-2031 (USD MILLION)
Figure 15. Global Chronic Disease Management Market, SERVICES -2019-2031 (USD MILLION)
Figure 16. Global Chronic Disease Management Market SHARE, By End User -2023 & 2031 (USD MILLION)
Figure 17. Global Chronic Disease Management Market, HEALTHCARE PROVIDERS -2019-2031 (USD MILLION)
Figure 18. Global Chronic Disease Management Market, HEALTHCARE PAYERS -2019-2031 (USD MILLION)
Figure 19. Global Chronic Disease Management Market, OTHERS -2019-2031 (USD MILLION)
Figure 20. MARKET PLAYER POSITIONING, 2022
Figure 21. COMPANY EVALUATION MATRIX
Figure 22. PRODUCT MAPPING OF TOP 10 PLAYERS
Figure 23. COMPETITIVE HEATMAP OF KEY PLAYERS

Frequently Asked Questions (FAQ):

  • Which is the leading segment in the Global Chronic Disease Management Market?

    Based on application, Solutions typically dominate the market.
  • What are the key factors driving the Global Chronic Disease Management Market?

    Advancements in Technology, Growing Awareness and Education are some of the key factors driving the growth in the market.
  • Which region will contribute notably towards the Global Chronic Disease Management Market?

    North America region to contribute the major share towards the market growth.
  • What are the key players in the Global Chronic Disease Management Market?

    Cedar Gate Technologies, Cognizant TriZetto Software Group Inc, Hinduja Global Solutions Ltd, Altruista Health, Koninklijke Philips N.V, Health Catalyst, ExlServings Holdings, Inc, Vivify Health, Inc, Pegasystems Inc, Epic Systems Corporation, Medecision, Casenet, LLC, cliexa, Inc, ZeOmega, NXGN Management, LLC, Infosys Ltd, Allscripts Healthcare, LLC and Others.

Buying Options

Original price was: $6,000.00.Current price is: $5,100.00.
Original price was: $5,000.00.Current price is: $4,500.00.
Original price was: $4,000.00.Current price is: $3,800.00.